Determination of in vitro activities of polymyxin B and rifampin in combination with ampicillin/sulbactam or cefoperazone/sulbactam against multidrug-resistant Acinetobacter baumannii by the E-test and checkerboard methods

Japanese Journal of Infectious Diseases

Volumn 66, Issue 6, 2013, Pages 463-468

  Sesli Cetin, Emel ^a   Tekeli, Alper ^b   Ozseven, Ayşe Gul ^c   Us, Ebru ^b   Aridogan, Buket Cicioglu ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c KAFKAS UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Ampicillin sulbactam; Cefoperazone sulbactam; Polymyxin B; Rifampin; Synergy tests

Indexed keywords

AMIKACIN; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CIPROFLOXACIN; IMIPENEM; MEROPENEM; POLYMYXIN B; RIFAMPICIN; SULTAMICILLIN; TICARCILLIN;

ACINETOBACTER BAUMANNII; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; CHECKERBOARD ASSAY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG POTENTIATION; EPSILOMETER TEST; IN VITRO STUDY; INTERMETHOD COMPARISON; MULTIDRUG RESISTANCE; NONHUMAN; TEST STRIP;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B; RIFAMPIN;

EID: 84888126692     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.463     Document Type: Article

References (24)

1. Peleg, A.Y., Seifert, H. and Paterson, D.L. (2008): Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev., 21, 538-582.
2. Poirel, L. and Nordmann, P. (2006): Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect., 12, 826-836.
3. Bonapace, C.R., White, R.L., Friedrich, L.V., et al. (2000): Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with E-test, time-kill and checkerboard methods. Diagn. Microbiol. Infect. Dis., 38, 43-50.
4. Zavascki, A.P., Carvalhaes, C.G., Picaã o, R.C., et al. (2010): Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev. Anti-Infect. Ther., 8, 71-93.
5. Hogg, G.M., Barr, J.G. and Webb, C.H. (1998): In-vitro activity of the combination of colistin and rifampicin against multidrug resistant strains of Acinetobacter baumannii. J. Antimicrob. Chemother., 41, 494-495.
6. Giamarellos-Bourboulis, E.J., Xirou chaki, E. and Giamarellou, H. (2001): Interactions of colistin and rifampicin on multi-drug resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis., 40, 117-120.
7. Gales, A.C., Jones, R.N. and Sader, H.S. (2006): Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin. Microbiol. Infect., 12, 315-321.
8. Lim, T.P., Tan, T.Y., Lee, W., et al. (2011): In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore. PLoS One, 21, 6, e18485.
9. Montero, A., Ariza, J., Corbella, X., et al. (2002): Efficacy of colistin versus β-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 46, 1946-1952.
10. Neonakis, I.K., Spandidos, D.A. and Petinaki, E. (2011): Confronting multidrug-resistant Acinetobacter baumannii: a review. Int. J. Antimicrob. Agents, 37, 102-109.
11. Clinical and Laboratory Standards Institute (2010): Performance standards for antimicrobial susceptibility testing; 20th informational supplement. Document M100-S20. CLSI, Wayne, Pa.
12. Anonymous (1992): Synergism testing: broth microdilution checkerboard and broth macrodilution methods. p. 5.18.1-5.18.28. In H.D. Isenberg (ed.), Clinical Microbiology Procedures Handbook. American Society for Microbiology, Washington, D.C.
13. Pillai, S.K., Moellering, R.C. and Eliopoulos, G.M. (2005): Antimicrobial combinations. p. 365-440. In V. Lorian (ed.), Antibiotics in Laboratory Medicine. 5th ed. Lippincott Williams & Wilkins, Philadelphia.
14. Us, E., Erdem, B., Tekeli, A., et al. (2009): Molecular investigation of Salmonella Choleraesuis and Salmonella Hadar strains isolated from humans in Turkey. Jpn. J. Infect. Dis., 62, 362-367.
15. Tenover, F.C., Arbeit, R.D., Goering, R.V., et al. (1995): Interpreting chromosomal DNA restriction patterns by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33, 2233-2239.
16. Song, J.Y., Cheong, H.J., Lee, J., et al. (2009): Efficacy of monotherapy and combined antibiotic therapy for carbapenemresistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Int. J. Antimicrob. Agents, 33, 33-39.
17. Tascini, C., Menichetti, F., Bozza, S., et al. (1998): Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii. J. Antimicrob. Chemother., 42, 270-271.
18. Maslow, J.N., Slutsky, A.M. and Arbeit, R.D. (1993): Application of pulsed-field gel electrophoresis to molecular epidemiology. p. 563-572. InH.D. Persing, T.F. Smith, F.C. Tenover, et al. (ed.), Diagnostic Molecular Microbiology: Principles and Applications. American Society for Microbiology, Washington, D.C.
19. Falagas, M.E. and Kopterides, P. (2006): Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J. Hosp. Infect., 64, 7-15.
20. Pongpech, P., Amornnopparattanakul, S., Panapakdee, S., et al. (2010): Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii. J. Med. Assoc. Thai., 93, 161-171.
21. Yoon, J., Urban, C., Terzian, C., et al. (2004): In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 48, 753-757.
22. Zavascki, A.P., Goldani, L.Z., Li, J., et al. (2007): Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J. Antimicrob. Chemother., 60, 1206-1215.
23. Pankey, G.A. and Ashcraft, D.S. (2009): The detection of synergy between meropenem and polymyxin B against meropenemresistant Acinetobacter baumannii using Etest and time-kill assay. Diagn. Microbiol. Infect. Dis., 63, 228-232.
24. Landman, D., Bratu, S., Kochar, S., et al. (2007): Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother., 60, 78-82.